Managers / Q2 2025 · view latest →
Hudson Value Partners, LLC
CIK 0001840501 · 2875 SOUTH OCEAN BLVD, SUITE 200-26, PALM BEACH, FL, 33480 · 646-343-9773
Summary
Hudson Value Partners, LLC reported $290M in U.S.-listed holdings across 110 positions for Q2 2025.
Its largest position, BRK/B, represents 7.3% of the portfolio.
Compared with Q1 2025, the fund opened 15 new positions and exited 6.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 88.8% · $257M
- ETP · 8.1% · $23M
- Other · 2.6% · $8M
- MLP · 0.5% · $1M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| TMOTHERMO FISHER SCIENTIFIC INC COM | NEW | +9.3K | 9.3K | +$4M | $4M |
| QXOQXO INC COM NEW | NEW | +75.6K | 75.6K | +$2M | $2M |
| ISHARES MSCI BRAZIL ETF | NEW | +29.5K | 29.5K | +$851,878 | $851,878 |
| MUMICRON TECHNOLOGY INC COM | NEW | +5.6K | 5.6K | +$689,584 | $689,584 |
| ABNBAIRBNB INC COM CL A | NEW | +3.7K | 3.7K | +$491,114 | $491,114 |
| CNRCORE NATURAL RESOURCES INC COM SHS | NEW | +6.4K | 6.4K | +$448,707 | $448,707 |
| REGNREGENERON PHARMACEUTICALS COM | NEW | +759 | 759 | +$398,475 | $398,475 |
| NVIDIA CORPORATION COM | NEW | +1.5K | 1.5K | +$236,985 | $236,985 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $335M | 101 | Apr 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $336M | 111 | Jan 28, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $323M | 113 | Oct 30, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $290M | 110 | Jul 18, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $266M | 100 | Apr 22, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024REVEALED | $269M | 92 | Feb 3, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $257M | 97 | Oct 31, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $237M | 91 | Jul 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $235M | 94 | May 8, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $215M | 94 | Feb 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $190M | 99 | Nov 2, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $196M | 105 | Aug 2, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $176M | 105 | May 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $163M | 102 | Jan 30, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $149M | 101 | Nov 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $158M | 100 | Jul 29, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $194M | 111 | Apr 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $206M | 115 | Jan 19, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $182M | 111 | Oct 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $181M | 116 | Jul 9, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $166M | 110 | Apr 19, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $149M | 111 | Feb 18, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.